March 22, 2024Cancer Research

Demographic and Clinical Disparities in Hepatocellular Carcinoma

View Full Paper

Ask AI

Bookmark

Alpha-FP levels vary significantly across hepatocellular carcinoma groups, showing higher expression in younger patients, males, and smokers.
Among 247 patients, Black individuals showed significantly higher aspartate aminotransferase (p=0.027) and cholesterol levels (p=0.0006).
A retrospective study stratified patients across demographic factors, comparing liver enzyme panels, lipid profiles, and comorbidity rates.
Highlights significant clinical variation among hepatocellular carcinoma subgroups, which may support improved personalized disease management.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Retrospective study reveals significant biomarker and comorbidity disparities in hepatocellular carcinoma, indicating tailored clinical management is needed.

Cite This Study

Zhou et al. (2024) studied this question.

synapsesocial.com/papers/68e72e34b6db6435876a7d6c https://doi.org/10.1158/1538-7445.am2024-822

View Full Paper

Ask AI

Bookmark

Implication

Retrospective study reveals significant biomarker and comorbidity disparities in hepatocellular carcinoma, indicating tailored clinical management is needed.

Demographic and Clinical Disparities in Hepatocellular Carcinoma

Key Points

Discussion

Implication

Cite This Study

Demographic and Clinical Disparities in Hepatocellular Carcinoma

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider